Abstract Details
| Nizar Chahin, MD | Dr. Chahin has nothing to disclose. |
| Eve Chanson | No disclosure on file |
| Andrew G. Engel, MD, FÂé¶¹´«Ã½Ó³» (Mayo Clinic Rochester) | The institution of Dr. Engel has received research support from NIH. |
| No disclosure on file | |
| Jon Eliasson | No disclosure on file |
| Frederic Taithe (CHU Gabriel Montpied) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Pierre Clavelou, MD, PhD (Hopital Gabriel Montpied) | Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. |